The Board of Directors of Analabs wishes to announce that the present mandate granted by the shareholders of the Company at the Twenty-Seventh Annual General Meeting held on 23 October 2025 to buy back its own shares will expire at the conclusion of the forthcoming Twenty-Eighth AGM ("28th AGM").

In this regard, the Company proposes to seek its shareholders' approval for the proposed renewal of authority for the Company to purchase its own shares up to a maximum of ten per centum (10%) of the total issued shares of the Company at the forthcoming 28th AGM.

A Statement to Shareholders detailing the Proposed Share Buy-Back will be despatched to the shareholders of the Company in due course.

This announcement is dated 25 June 2026.